contraindications of glp 1 Table 5 from Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists Drug Class Review Contraindications for switching. | Download

The GLP-1 drugs market size is predicted to grow from USD 58.05 billion in 2026 to USD 132.79 billion by 2035, driven by a CAGR of 9.63%.

Initially

If any of the criteria above cannot be met and you are not satisfied with the product, please reach out anyways and we will evaluate on a case-by-case basis

Ro, the leading direct-to-patient healthcare company, today announced that it is working with Eli Lilly to launch the recently FDA-approved Zepbound (tirzepatide) KwikPen nationwide on its platform

In this weeks new products roundup, Nestl rolls out another product geared toward GLP-1 users, Minus Coffee transitions from RTDs to instant powdered lattes, and Cann teams up with Sober(ish) for Dry January.

Expert panelists will address everything from how employers are handling covering the new drug to what patients are asking for.